Sanofi (SNYNF)
OTCMKTS · Delayed Price · Currency is USD
95.90
+0.02 (0.02%)
Dec 19, 2025, 9:30 AM EST
Sanofi Employees
Sanofi had 82,878 employees as of December 31, 2024. The number of employees decreased by 3,210 or -3.73% compared to the previous year.
Employees
82,878
Change (1Y)
-3,210
Growth (1Y)
-3.73%
Revenue / Employee
$650,241
Profits / Employee
$129,012
Market Cap
116.72B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 82,878 | -3,210 | -3.73% |
| Dec 31, 2023 | 86,088 | -5,485 | -5.99% |
| Dec 31, 2022 | 91,573 | -3,869 | -4.05% |
| Dec 31, 2021 | 95,442 | -3,970 | -3.99% |
| Dec 31, 2020 | 99,412 | -997 | -0.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Jushi Holdings | 1,234 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| OpGen | 1 |
Sanofi News
- 7 hours ago - Sanofi a Top Ranked SAFE Dividend Stock With 4.6% Yield (SNY) - Nasdaq
- 2 days ago - Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal - Benzinga
- 2 days ago - Nine pharmaceutical companies including Bristol-Myers Squibb, GSK and Merck agreed to lower the prices that certain federal government programs and patients pay - WSJ
- 3 days ago - Trump strikes deal with US drugmakers to cut Medicaid medicine costs - The Guardian
- 3 days ago - Nine of the largest pharma companies ink deals with Trump to lower drug prices - CNBC
- 3 days ago - Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation - GlobeNewsWire
- 4 days ago - SNY's Rare Disease Drug Efdoralprin Alfa Gets EMA's Orphan Drug Tag - Nasdaq
- 5 days ago - Sanofi Receives EMA Orphan Designation For Efdoralprin Alfa - Nasdaq